<SUBMISSION>
<ACCESSION-NUMBER>0000950153-07-001219
<TYPE>8-K
<PUBLIC-DOCUMENT-COUNT>2
<PERIOD>20070523
<ITEMS>7.01
<ITEMS>9.01
<FILING-DATE>20070524
<DATE-OF-FILING-DATE-CHANGE>20070524
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>TASER INTERNATIONAL INC
<CIK>0001069183
<ASSIGNED-SIC>3480
<IRS-NUMBER>860741227
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>8-K
<ACT>34
<FILE-NUMBER>001-16391
<FILM-NUMBER>07877818
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>7860 EAST MCLAIN DR.
<STREET2>SUITE 2
<CITY>SCOTTSDALE
<STATE>AZ
<ZIP>85260
<PHONE>4809052000
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>7860 EAST MCLAIN DR.
<STREET2>SUITE 2
<CITY>SCOTTSDALE
<STATE>AZ
<ZIP>85260
</MAIL-ADDRESS>
</FILER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>p73932e8vk.htm
<DESCRIPTION>8-K
<TEXT>
<HTML>
<HEAD>
<TITLE>e8vk</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>




<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>UNITED STATES SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>Washington, DC 20549</B>
</DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>FORM 8-K</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>CURRENT REPORT<BR>
Pursuant to Section&nbsp;13 or 15(d) of<BR>
The Securities Exchange Act of 1934</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Date of Report (Date of earliest event reported)<BR>
May&nbsp;23, 2007</B></DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B>TASER International, Inc.</B>
</DIV>

<DIV align="center" style="font-size: 10pt">(Exact name of registrant as specified in its charter)</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Delaware</B><BR>
(State or other jurisdiction of <BR>
incorporation)</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>001-16391</B><BR>
(Commission File Number)</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>86-0741227</B><BR>
(IRS Employer<BR>
Identification No.)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>17800 N.
85</B><SUP style="font-size: 85%; vertical-align: text-top"><B>th</B></SUP> <B>St.<BR>
Scottsdale, Arizona 85255</B><BR>
(Address of principal executive offices, including zip code)<BR>
<B>(480)&nbsp;991-0797</B><BR>
(Registrant&#146;s telephone number, including area code)<BR>
(Former name or former address, if changed since last report)</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><FONT face="Wingdings">&#111;</FONT> Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><FONT face="Wingdings">&#111;</FONT> Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><FONT face="Wingdings">&#111;</FONT> Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><FONT face="Wingdings">&#111;</FONT> Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
</DIV>


<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left">
<!-- TOC -->
</DIV>
<DIV align="left">
<A name="tocpage"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U><B>TABLE OF CONTENTS</B></U>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#101">ITEM 7.01. REGULATION FD DISCLSOURE</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#102">ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#103">SIGNATURES</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><A href="#104">EXHIBIT INDEX</A></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Body -->
<TR><TD colspan="9"><FONT size="2">&nbsp;<A HREF="p73932exv99w1.htm">EX-99.1</A></FONT></TD></TR>
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left">
<!-- /TOC -->
</DIV>



<DIV align="left">
<A name="101"></A>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>ITEM 7.01. REGULATION FD DISCLOSURE.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">On May&nbsp;23, 2007 TASER International,
Inc. (the &#147;Company&#148;) announced that Patrick Smith, CEO of
TASER International, Inc., and Thomas Smith, Chairman of TASER International, Inc., adopted a stock
trading plan in accordance with Rule&nbsp;10b5-1 of the Securities Act of 1934. In addition TASER
International, Inc announced that Patrick Smith has exercised nonqualified stock options to acquire
504,000 shares of TASER common stock which expire on May&nbsp;29, 2007 and executed a &#147;cashless&#148;
exercise for a portion of these nonqualified stock options under which approximately 100,000 option
shares were sold on the open market to fund the acquisition of the balance of 404,000 option shares
being acquired through an &#147;exercise and hold.&#148; The public announcement was made by means of a
press release, the text of which is set forth in Exhibit&nbsp;99.1 hereto.
</DIV>

<DIV align="left">
<A name="102"></A>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exhibits.
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="92%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">Exhibit No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">Description</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Press Release dated May&nbsp;23, 2007</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>Information presented in this Current Report on Form 8-K may contain forward-looking
statements and certain assumptions upon which such forward-looking statements are in part based.
Numerous important factors, including those factors identified as in the Yellow Roadway Annual
Report on Form 10-K and other of the Company&#146;s filings with the Securities and Exchange Commission,
and the fact that the assumptions set forth in this Current Report on Form 8-K could prove
incorrect, could cause actual results to differ materially from those contained in such
forward-looking statements.</I>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><I>Information in this Current Report that is being furnished pursuant to Item&nbsp;7.01 shall not be
deemed &#147;filed&#148; for the purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended,
or otherwise subject to the liabilities of that Section. The information furnished pursuant to
Item&nbsp;7.01 in this Current Report shall not be incorporated by reference into any registration
statement pursuant to the Securities Act of 1933, as amended. The furnishing of the information in
Item&nbsp;7.01 of this Current Report is not intended to, and does not, constitute a representation that
such furnishing is required by Regulation&nbsp;FD or that the information Item&nbsp;7.01 of this Current
Report contains is material investor information that is not otherwise publicly available.</I>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left">
<A name="103"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SIGNATURES</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">Dated: May 24, 2007&nbsp;</TD>
    <TD colspan="3" align="left">TASER International, Inc.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">                                /s/ DANIEL BEHRENDT
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Daniel Behrendt&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Chief Financial Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always"><A HREF="#tocpage">Table of Contents</A></H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>

</TABLE>

<DIV align="left">
<A name="104"></A>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">EXHIBIT INDEX
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="5%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="92%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000">Exhibit No.</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">Description</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Press Release dated May&nbsp;23, 2007</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>p73932exv99w1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
<TITLE>exv99w1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Exhibit&nbsp;99.1
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>For Immediate Release: May&nbsp;23, 2007</B>
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="42%" style="background: transparent">&nbsp;</TD>
    <TD width="10%" nowrap align="left"><B>CONTACT: </B></TD>
    <TD width="1%"><B>&nbsp;</B></TD>
    <TD>Dan Behrendt<BR><BR>
CFO<BR><BR>
TASER International, Inc.<BR><BR>
(480)&nbsp;905-2000</TD>
</TR>
</TABLE>
</DIV>

<DIV align="center" style="font-size: 14pt; margin-top: 18pt"><B>TASER International CEO Exercises Expiring Options</B>
</DIV>


<DIV align="center" style="font-size: 14pt; margin-top: 6pt"><B>and Establishes 10b5-1 Trading Plan</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 18pt">SCOTTSDALE, AZ, May&nbsp;23, 2007 &#151; TASER International, Inc. (NASDAQ: TASR) a market leader in
advanced electronic control devices today announced that Chief Executive Officer Rick Smith has
exercised nonqualified stock options to acquire 504,000 shares of TASER common stock which expire
on May&nbsp;29, 2007 and has adopted a stock trading plan in accordance with Rule&nbsp;10b5-1 of the
Securities Exchange Act of 1934 related to the sale of 500,000 shares. Similarly, Tom Smith,
Chairman of TASER International&#146;s Board of Directors, has also adopted a stock trading plan in
accordance with Rule&nbsp;10b5-1. The Smiths&#146; plans are a component of their overall tax and financial
planning strategy that is designed to provide enhanced diversification and liquidity relating to
taxes and acquisition costs associated with the exercise of the stock options.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Rule&nbsp;10b5-1 enables corporate officers and directors to establish stock trading plans for the
orderly sale of predetermined amounts of securities. Such plans may be initiated only when the
officers and directors are not in possession of material and non-public information. The rule
allows individuals adopting such plans to sell shares over a specified amount of time at specific
prices in the future, even if subsequent material and non-public information becomes available to
them.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Rick Smith executed a &#147;cashless&#148; exercise for a portion of these nonqualified stock options under
which approximately 100,000 option shares were sold on the open market to fund the
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">acquisition of the balance of 404,000 option shares being acquired through an &#147;exercise and hold.&#148;
Under the provisions of Rick Smith&#146;s 10b5-1 plan, up to 500,000 shares may be sold, which, together
with the approximate 100,000 option shares sold in the &#147;cashless&#148; exercise, represent 19% of the
3,171,376 shares he controls (2,765,208 shares owned and 406,168 in remaining vested stock
options). Any transactions executed under the provisions of the plan, which is effective for
approximately 12&nbsp;months starting in the third quarter of 2007, will be reported on Form&nbsp;4 filings
with the Securities and Exchange Commission. There are no assurances that any shares will be sold
during the duration of the plan.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Under the provisions of Tom Smith&#146;s 10b5-1 plan, up to 375,000 shares may be sold, representing 19%
of the 1,970,256 shares he controls (1,040,088 shares owned and 930,168 remaining vested stock
options). Any transactions executed under the provisions of the plan, which is effective for
approximately 12&nbsp;months starting in the third quarter of 2007, will be reported on Form&nbsp;4 filings
with the Securities and Exchange Commission. There are no assurances that any shares will be sold
during the duration of the plan.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>About TASER International, Inc.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">TASER International provides advanced electronic control devices for use in the law
enforcement, military, private security and personal defense markets. TASER<SUP style="font-size: 85%; vertical-align: text-top">&#174;</SUP> devices
use proprietary technology to incapacitate dangerous, combative or high-risk subjects who pose a
risk to law enforcement officers, innocent citizens or themselves in a manner that is generally
recognized as a safer alternative to other uses of force. TASER technology saves lives every day,
and the use of TASER devices dramatically reduces injury rates for police officers and suspects.
For more information on TASER life-saving technology, please call TASER International at (800)
978-2737 or visit our website at www.TASER.com.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Note to Investors</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">This press release contains forward-looking information within the meaning of Section&nbsp;27A of the
Securities Act of the 1933 and Section&nbsp;21E of the Securities Exchange Act of 1934, and is subject
to the safe harbor created by those sections. The forward-looking information is based upon
current information and expectations regarding TASER International. These estimates and statements
speak only as of the date on which they are made, are not guarantees of future performance, and
involve certain risks, uncertainties and assumptions that are difficult to predict. Therefore,
actual outcomes and results could materially differ from what is expressed, implied, or forecasted
in such forward-looking statements.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">TASER International assumes no obligation to update the information contained in this press
release. TASER International&#146;s forward looking statements in this press release and future results
may be impacted by
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">risks
associated with rapid technological change, new product introductions, new technological
developments and implementations, execution issues associated with new technology, ramping
manufacturing production to meet demand, litigation results from Company filed lawsuits and other
litigation including lawsuits resulting from alleged product related injuries, media publicity
concerning allegations of deaths occurring after use of the TASER device and the negative impact
this could have on sales, product quality, implementation of manufacturing automation, potential
fluctuations in quarterly operating results, adjustments to these amounts which may be reflected in
our 10Q filing, competition, financial and budgetary constraints of prospects and customers,
international order delays, dependence upon sole and limited source suppliers, negative reports
concerning TASER device uses, governmental inquiries and investigations, medical and safety
studies, fluctuations in component pricing, government regulations, variation among law enforcement
agencies with their TASER product experience, TASER device tests and reports, dependence upon key
employees, and our ability to retain employees. TASER International&#146;s future results may also be
impacted by other risk factors listed from time to time in its SEC filings, including, but not
limited to, the Company&#146;s Form 10-QSBs and its Annual Report on Form 10-KSB.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The statements made herein are independent statements of TASER International. The inclusion of any
third parties does not represent an endorsement of any TASER International products or services by
any such third parties.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"># # #
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SUBMISSION>
